Prostate brachytherapy using (125)iodine (I-125), with the addition of exte
rnal beam radiation in select patients, provides excellent long-term diseas
e control. The majority (75%) of disease recurrence cases are confirmed wit
h a positive biopsy, on radiography or with consecutive prostate specific a
ntigen (PSA) increases within the first 5 years of treatment. We report a c
ase of metastasis in the original tract of the I-125 implantation 8 years a
fter treatment.